ADVM Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.20%

Insider Buying (Last 12 Months): $1,798,951.50

Insider Selling (Last 12 Months): $0.00

Adverum Biotechnologies Insider Trading History Chart

Adverum Biotechnologies Share Price & Price History

^$6.04

▲ +0.29 (5.04%)

As of 11/22/2024 01:00 AM ET

Days: 30 | 90 | 365

50-year Wall Street legend: “Sell this tech stock NOW”

From Chaikin Analytics | Ad

Something very strange is happening to U.S. stocks following President Trump's victory... And this could spell disaster for some of America's favorite tech companies.

You can watch for it for free, right here.

Adverum Biotechnologies Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
7/30/2024	Braden Michael Leonard	Major Shareholder	Buy	85,800	$7.15	$613,470.00	2,268,064
7/17/2024	Braden Michael Leonard	Major Shareholder	Buy	135,546	$7.75	$1,050,481.50	2,101,546
2/7/2024	James Paul Scopa	Director	Buy	10,000	$13.50	$135,000.00	10,000
9/15/2023	Setareh Seyedkazemi	Insider	Sell	620	$15.20	$9,424.00	4,767
3/15/2023	Brigit Riley	Insider	Sell	729	$7.80	$5,686.20	11,743
3/15/2023	Laurent Fischer	CEO	Sell	4,123	$7.80	$32,159.40	69,214
3/15/2023	Kishor Peter Soparkar	COO	Sell	1,336	$7.80	$10,420.80	26,589
9/19/2022	Laurent Fischer	CEO	Sell	4,108	$10.70	$43,955.60	72,738
9/19/2022	Richard Beckman	Insider	Sell	427	$10.70	$4,568.90	3,906
5/23/2022	Setareh Seyedkazemi	Insider	Buy	2,000	$8.40	$16,800.00	2,060
5/17/2022	Rupert D'souza	CFO	Buy	1,000	$8.30	$8,300.00	2,085
5/16/2022	Dawn Svoronos	Director	Buy	3,000	$8.50	$25,500.00	5,000
5/13/2022	Rupert D'souza	CFO	Buy	1,000	$8.60	$8,600.00	1,085
4/20/2022	Laurent Fischer	CEO	Buy	2,500	$11.10	$27,750.00	76,246
4/19/2022	Kishor Peter Soparkar	Insider	Buy	2,192	$11.40	$24,988.80	28,055
12/8/2021	Laurent Fischer	CEO	Buy	1,067	$17.90	$19,099.30
12/8/2021	Kishor Peter Soparkar	Insider	Buy	2,500	$19.10	$47,750.00

50-year Wall Street legend: “Sell this tech stock NOW”

From Chaikin Analytics | Ad

Something very strange is happening to U.S. stocks following President Trump's victory... And this could spell disaster for some of America's favorite tech companies.

You can watch for it for free, right here.

SEC Filings (Institutional Ownership Changes) for Adverum Biotechnologies (NASDAQ:ADVM)

48.17% of Adverum Biotechnologies stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Adverum Biotechnologies Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/19/2024	Barclays PLC	35,832	$0.25M	0.0%	+125.8%	0.172%
11/16/2024	Geode Capital Management LLC	439,056	$3.08M	0.0%	-3.7%	2.111%
11/15/2024	Barclays PLC	35,832	$0.25M	0.0%	+125.8%	0.172%
11/15/2024	Zacks Investment Management	12,617	$89K	0.0%	N/A	0.061%
11/15/2024	State Street Corp	369,616	$2.60M	0.0%	+32.7%	1.777%
11/14/2024	Captrust Financial Advisors	10,115	$71K	0.0%	N/A	0.049%
11/14/2024	MetLife Investment Management LLC	12,582	$88K	0.0%	+129.1%	0.060%
11/13/2024	BNP Paribas Financial Markets	4,146	$29K	0.0%	+177.0%	0.020%
11/13/2024	FMR LLC	234,718	$1.65M	0.0%	-63.2%	1.128%
11/8/2024	Connor Clark & Lunn Investment Management Ltd.	13,204	$93K	0.0%	N/A	0.063%
11/5/2024	BML Capital Management LLC	2,268,064	$15.92M	9.4%	+15.4%	10.904%
10/23/2024	Assenagon Asset Management S.A.	23,413	$0.16M	0.0%	-96.2%	0.113%
10/3/2024	SG Americas Securities LLC	10,597	$74K	0.0%	N/A	0.051%
8/27/2024	Logos Global Management LP	416,666	$2.86M	0.2%	-72.2%	2.007%
8/14/2024	Squarepoint Ops LLC	108,978	$0.75M	0.0%	+301.1%	0.525%
8/14/2024	Marshall Wace LLP	204,619	$1.40M	0.0%	+52.9%	0.986%
8/14/2024	Logos Global Management LP	416,666	$2.86M	0.2%	-72.2%	2.007%
8/9/2024	Renaissance Technologies LLC	136,257	$0.94M	0.0%	+2.4%	0.656%
8/9/2024	Dimensional Fund Advisors LP	223,427	$1.53M	0.0%	+741.8%	1.076%
8/1/2024	Rhumbline Advisers	30,821	$0.21M	0.0%	+10,419.1%	0.148%
7/26/2024	Bank of New York Mellon Corp	64,585	$0.44M	0.0%	N/A	0.311%
7/18/2024	Assenagon Asset Management S.A.	617,910	$4.24M	0.0%	+72.3%	2.976%
5/15/2024	Avoro Capital Advisors LLC	416,666	$5.89M	0.1%	N/A	2.007%
5/10/2024	Acadian Asset Management LLC	2,902	$41K	0.0%	-89.6%	0.014%
5/10/2024	Vanguard Group Inc.	907,151	$12.83M	0.0%	-78.3%	4.370%
5/9/2024	Picton Mahoney Asset Management	123,966	$1.76M	0.1%	N/A	0.597%
5/3/2024	Versant Venture Management LLC	506,822	$7.17M	6.9%	-90.0%	2.442%
4/24/2024	Assenagon Asset Management S.A.	358,719	$5.07M	0.0%	N/A	1.729%
4/23/2024	BML Capital Management LLC	833,117	$11.78M	7.8%	-81.7%	4.014%
4/22/2024	Vivo Capital LLC	1,500,000	$21.21M	1.7%	N/A	7.229%
3/5/2024	Twin Focus Capital Partners LLC	100,000	$75K	0.0%	N/A	0.099%
2/12/2024	AIGH Capital Management LLC	3,172,819	$2.39M	0.9%	+139.6%	3.140%
2/9/2024	Worth Venture Partners LLC	784,346	$0.59M	0.3%	+136.5%	0.776%
2/8/2024	Apexium Financial LP	60,000	$45K	0.0%	N/A	0.059%
2/7/2024	Monaco Asset Management SAM	79,234	$60K	0.0%	+33.8%	0.078%
1/30/2024	BML Capital Management LLC	4,554,252	$3.43M	2.6%	+16.3%	4.508%
12/6/2023	Citigroup Inc.	476,692	$0.72M	0.0%	N/A	0.472%
11/15/2023	Worth Venture Partners LLC	331,668	$0.50M	0.3%	-10.5%	0.328%
11/14/2023	Newtyn Management LLC	1,025,000	$1.54M	0.4%	+2.5%	1.015%
11/13/2023	FMR LLC	6,691,925	$10.04M	0.0%	-13.8%	6.626%
11/13/2023	AIGH Capital Management LLC	1,323,985	$1.99M	0.9%	-10.8%	1.311%
11/9/2023	Citigroup Inc.	476,692	$0.72M	0.0%	N/A	0.472%
11/7/2023	Monaco Asset Management SAM	59,234	$89K	0.0%	-74.8%	0.059%
10/27/2023	Marquette Asset Management LLC	60,120	$90K	0.0%	-50.5%	0.060%
10/27/2023	Acuitas Investments LLC	291,169	$0.44M	0.3%	-52.5%	0.288%
10/23/2023	BML Capital Management LLC	3,915,000	$5.87M	5.4%	-24.1%	3.877%
8/15/2023	Commodore Capital LP	10,000,000	$15.90M	1.8%	+100.0%	9.902%
8/11/2023	VR Adviser LLC	3,886,246	$6.18M	1.0%	N/A	3.864%
8/8/2023	Monaco Asset Management SAM	235,000	$0.37M	0.1%	-64.4%	0.234%
7/24/2023	BML Capital Management LLC	5,157,179	$8.20M	7.4%	-27.0%	5.128%
5/15/2023	Commodore Capital LP	5,000,000	$3.59M	0.5%	N/A	4.971%
5/15/2023	Sonic GP LLC	2,000,000	$1.44M	1.1%	-56.1%	1.989%
5/10/2023	Connor Clark & Lunn Investment Management Ltd.	149,856	$0.11M	0.0%	-25.3%	0.149%
5/8/2023	CM Management LLC	375,000	$0.27M	0.3%	+275.0%	0.373%
2/13/2023	BML Capital Management LLC	7,067,179	$4.10M	3.9%	N/A	7.086%
2/13/2023	GSA Capital Partners LLP	830,829	$0.48M	0.1%	+950.7%	0.833%
2/9/2023	CM Management LLC	100,000	$58K	0.1%	N/A	0.100%
2/3/2023	Monaco Asset Management SAM	659,575	$0.38M	0.1%	+193.1%	0.661%
1/31/2023	Monaco Asset Management SAM	659,575	$0.38M	0.1%	+193.1%	0.661%
1/12/2023	Assenagon Asset Management S.A.	840,651	$0.49M	0.0%	-10.7%	0.843%
1/12/2023	Marquette Asset Management LLC	121,393	$70K	0.0%	+25.3%	0.122%
11/15/2022	Quinn Opportunity Partners LLC	418,298	$0.40M	0.0%	-16.8%	0.419%
11/15/2022	Caas Capital Management LP	134,338	$0.13M	0.0%	N/A	0.135%
11/14/2022	Worth Venture Partners LLC	298,560	$0.28M	0.2%	+20.0%	0.302%
11/14/2022	Tudor Investment Corp Et Al	62,651	$60K	0.0%	N/A	0.063%
11/14/2022	683 Capital Management LLC	100,000	$95K	0.0%	-51.7%	0.101%
11/14/2022	Ergoteles LLC	368,684	$0.35M	0.0%	-12.2%	0.373%
11/10/2022	Connor Clark & Lunn Investment Management Ltd.	203,725	$0.19M	0.0%	+73.4%	0.206%
10/31/2022	Monaco Asset Management SAM	225,000	$0.21M	0.1%	-49.7%	0.228%
10/6/2022	Marquette Asset Management LLC	96,910	$92K	0.0%	-27.0%	0.098%
8/12/2022	Rafferty Asset Management LLC	69,954	$84K	0.0%	+55.9%	0.071%
8/5/2022	Connor Clark & Lunn Investment Management Ltd.	117,512	$0.14M	0.0%	-61.2%	0.119%
8/1/2022	Monaco Asset Management SAM	447,004	$0.54M	0.2%	N/A	0.453%
7/27/2022	Assenagon Asset Management S.A.	941,751	$1.13M	0.0%	-5.1%	0.953%
7/15/2022	Marquette Asset Management LLC	132,769	$0.16M	0.0%	+101.9%	0.134%
5/17/2022	RTW Investments LP	223,725	$0.29M	0.0%	-97.0%	0.227%
5/12/2022	Connor Clark & Lunn Investment Management Ltd.	302,717	$0.40M	0.0%	-10.6%	0.307%
5/11/2022	GSA Capital Partners LLP	395,585	$0.52M	0.1%	-24.3%	0.401%
5/10/2022	Mirae Asset Global Investments Co. Ltd.	387,623	$0.51M	0.0%	-9.2%	0.393%
5/5/2022	Russell Investments Group Ltd.	76,637	$100K	0.0%	-50.0%	0.078%
4/26/2022	Marquette Asset Management LLC	65,754	$86K	0.0%	+21.8%	0.067%
4/25/2022	Assenagon Asset Management S.A.	992,729	$1.30M	0.0%	+125.8%	1.005%
2/15/2022	683 Capital Management LLC	100,000	$0.18M	0.0%	-50.0%	0.102%
2/14/2022	Quinn Opportunity Partners LLC	503,004	$0.89M	0.1%	+102.8%	0.512%
2/14/2022	GSA Capital Partners LLP	522,284	$0.92M	0.1%	N/A	0.532%
2/11/2022	K2 Principal Fund L.P.	420,944	$0.74M	0.0%	-74.5%	0.429%
2/10/2022	Rafferty Asset Management LLC	49,107	$86K	0.0%	+47.9%	0.050%
2/10/2022	Connor Clark & Lunn Investment Management Ltd.	338,740	$0.60M	0.0%	-8.1%	0.345%
2/9/2022	BNP Paribas Arbitrage SA	175,109	$0.31M	0.0%	+872.0%	0.178%
2/9/2022	Dimensional Fund Advisors LP	687,130	$1.21M	0.0%	-8.1%	0.700%
2/9/2022	First Republic Investment Management Inc.	16,167	$28K	0.0%	-35.8%	0.016%
2/8/2022	Mirae Asset Global Investments Co. Ltd.	427,008	$0.75M	0.0%	+58.8%	0.435%
2/8/2022	Northern Trust Corp	790,397	$1.39M	0.0%	-9.9%	0.805%
2/7/2022	SG Americas Securities LLC	24,489	$43K	0.0%	-64.5%	0.025%
2/1/2022	Assenagon Asset Management S.A.	439,574	$0.77M	0.0%	-70.0%	0.448%
1/21/2022	Russell Investments Group Ltd.	153,337	$0.27M	0.0%	-31.8%	0.156%
1/19/2022	Marquette Asset Management LLC	54,000	$95K	0.0%	+18.4%	0.055%
12/14/2021	UBS Asset Management Americas Inc.	173,979	$0.38M	0.0%	+26.2%	0.177%
11/16/2021	Squarepoint Ops LLC	33,825	$73K	0.0%	+26.2%	0.034%
11/16/2021	Two Sigma Advisers LP	1,766,900	$3.83M	0.0%	+81.2%	1.800%

Data available starting January 2016

Adverum Biotechnologies, Inc., a clinical-stage company, develops gene therapy product candidates to treat ocular diseases. Its lead product candidate is ixoberogene soroparvovec (ADVM-022), a single intravitreal injection gene therapy candidate used for the treatment of patients with wet age-related macular degeneration and diabetic macular edema which is in phase 2 clinical trials. The company is developing ADVM-062 (AAV.7m8-L-opsin), a novel gene therapy product candidate for the treatment of blue cone monochromacy via a single IVT injection. Adverum Biotechnologies, Inc. has license and collaboration agreements with University of California; GenSight Biologics; Lexeo Therapeutics; and Virovek, Inc. The company was formerly known as Avalanche Biotechnologies, Inc. and changed its name to Adverum Biotechnologies, Inc. in May 2016. Adverum Biotechnologies, Inc. was incorporated in 2006 and is headquartered in Redwood City, California.

Today's Range

Now: $6.04

$5.69

$6.15

50 Day Range

MA: $7.42

$5.80

$8.48

52 Week Range

Now: $6.04

$5.69

$29.70

Volume

452,149 shs

Average Volume

280,681 shs

Market Capitalization

$125.64 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.02

Who are the company insiders with the largest holdings of Adverum Biotechnologies?: Adverum Biotechnologies' top insider shareholders include:
Braden Michael Leonard (Major Shareholder)
Laurent Fischer (CEO)
Peter Soparkar (COO)
Brigit Riley (Insider)
James Paul Scopa (Director)
Setareh Seyedkazemi (Insider)
Learn More about top insider investors at Adverum Biotechnologies.
Who are the major institutional investors of Adverum Biotechnologies?: Adverum Biotechnologies' top institutional shareholders include:
BML Capital Management LLC — 10.90%
Geode Capital Management LLC — 2.11%
State Street Corp — 1.78%
FMR LLC — 1.13%
Barclays PLC — 0.17%
Barclays PLC — 0.17%
Learn More about top institutional investors of Adverum Biotechnologies stock.
Which major investors are selling Adverum Biotechnologies stock?: Within the previous quarter, ADVM stock was sold by these institutional investors:
Assenagon Asset Management S.A.
FMR LLC
Geode Capital Management LLC
Belvedere Trading LLC
Which major investors are buying Adverum Biotechnologies stock?: During the last quarter, ADVM stock was acquired by institutional investors including:
BML Capital Management LLC
State Street Corp
Barclays PLC
Barclays PLC
Connor Clark & Lunn Investment Management Ltd.
Zacks Investment Management
SG Americas Securities LLC
Captrust Financial Advisors
In the last year, these company insiders have bought Adverum Biotechnologies stock:
Braden Michael Leonard (Major Shareholder)
Laurent Fischer (CEO)
Learn More investors buying Adverum Biotechnologies stock.